Real-time enrollment status for this thyroid eye disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06625398 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Thyroid Eye Disease |
| Phase | Clinical Trial |
| Target Enrollment | 195 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Viridian Therapeutics, Inc. |
| Last Updated on CT.gov | September 30, 2025 (Sep 30, 2025) |
As of March 2, 2026: Clinical trial NCT06625398 is currently active_not_recruiting participants. This clinical trial study for thyroid eye disease is not currently accepting new participants at 37 locations across the United States. The study is sponsored by Viridian Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06625398 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06625398 was last updated Sep 30, 2025 (September 30, 2025). HelloStudys verifies this status automatically.